Your browser doesn't support javascript.
loading
Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness.
Burrows, Holly; Antillón, Marina; Gauld, Jillian S; Kim, Jong-Hoon; Mogasale, Vittal; Ryckman, Theresa; Andrews, Jason R; Lo, Nathan C; Pitzer, Virginia E.
Affiliation
  • Burrows H; Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: holly.burrows@princeton.edu.
  • Antillón M; Yale School of Public Health, Yale University, New Haven, CT, USA; Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
  • Gauld JS; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Kim JH; Public Health, Access, and Vaccine Epidemiology (PAVE) Unit, International Vaccine Institute, Seoul, Republic of Korea.
  • Mogasale V; Policy and Economic Research Department, International Vaccine Institute, Seoul 08826, Republic of Korea.
  • Ryckman T; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Lo NC; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Pitzer VE; Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: virginia.pitzer@yale.edu.
Vaccine ; 41(4): 965-975, 2023 Jan 23.
Article de En | MEDLINE | ID: mdl-36586741

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fièvre typhoïde / Vaccins antityphoparatyphoïdiques Type d'étude: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Humans Langue: En Journal: Vaccine Année: 2023 Type de document: Article Pays de publication: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fièvre typhoïde / Vaccins antityphoparatyphoïdiques Type d'étude: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Humans Langue: En Journal: Vaccine Année: 2023 Type de document: Article Pays de publication: Pays-Bas